We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
CDK4/CDK6 Inhibitors Effective in Older Women, but Have More Side Effects.
- Authors
Starr, Phoebe
- Abstract
The article focuses on the pooled analysis of clinical trials presented at the 2017 San Antonio Breast Cancer Symposium which reveals that older patients with hormone receptor–positive, HER2-negative, metastatic breast cancer derive similar benefit as younger patients who received cyclin-dependent kinase (CDK)4/CDK6 inhibitors during initial endocrine therapy. It mentions that the eligibility criteria for clinical trials should be based on patient-reported outcomes and realworld data.
- Subjects
BREAST cancer conferences; BREAST cancer treatment; HORMONE therapy; BREAST cancer patients; CLINICAL trials
- Publication
Oncology Practice Management, 2018, Vol 8, Issue 2, p17
- ISSN
2164-4403
- Publication type
Proceeding